A review on the role of moisturizers for atopic dermatitis
Effective management of atopic dermatitis (AD) involves the treatment of a defective skin barrier. Patients with AD are therefore advised to use moisturizers regularly. To date, there are few comparative studies involving moisturizers in patients with AD, and no classification system exists to objectively determine which types of moisturizers are best suited to specific AD phenotypes. With this in mind, a group of experts from allergy and immunology, adult and pediatric dermatology, and pediatrics centers within Southeast Asia met to review current data and practice, and to develop recommendations regarding the use of moisturizers in patients with AD within the Asia-Pacific region. Chronicity and severity of AD, along with patient age, treatment compliance, and economic background should all be taken into account when selecting an appropriate moisturizer for AD patients. Other considerations include adjuvant properties of the product, cosmetic acceptability, and availability over the counter. Well-defined clinical phenotypes of AD could optimally benefit from specific moisturizers. It is hoped that future studies may identify such differences by means of filaggrin mutation subtypes, confocal microscopic evaluation, pH, transepidermal water loss or presence of allergy specific IgE. Recommendations to improve the regular use of moisturizers among AD patients include measures that focus on treatment compliance, patient and caregiver education, appropriate treatment goals, avoidance of sensitizing agents, and collaboration with other relevant specialists.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:6 |
|---|---|
| Enthalten in: |
Asia Pacific allergy - 6(2016), 2 vom: 01. Apr., Seite 120-8 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Giam, Yoke Chin [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Asia Pacific |
|---|
| Anmerkungen: |
Date Completed 04.05.2016 Date Revised 30.03.2022 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.5415/apallergy.2016.6.2.120 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM259987522 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM259987522 | ||
| 003 | DE-627 | ||
| 005 | 20231226192814.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.5415/apallergy.2016.6.2.120 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0866.xml |
| 035 | |a (DE-627)NLM259987522 | ||
| 035 | |a (NLM)27141486 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Giam, Yoke Chin |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A review on the role of moisturizers for atopic dermatitis |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.05.2016 | ||
| 500 | |a Date Revised 30.03.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Effective management of atopic dermatitis (AD) involves the treatment of a defective skin barrier. Patients with AD are therefore advised to use moisturizers regularly. To date, there are few comparative studies involving moisturizers in patients with AD, and no classification system exists to objectively determine which types of moisturizers are best suited to specific AD phenotypes. With this in mind, a group of experts from allergy and immunology, adult and pediatric dermatology, and pediatrics centers within Southeast Asia met to review current data and practice, and to develop recommendations regarding the use of moisturizers in patients with AD within the Asia-Pacific region. Chronicity and severity of AD, along with patient age, treatment compliance, and economic background should all be taken into account when selecting an appropriate moisturizer for AD patients. Other considerations include adjuvant properties of the product, cosmetic acceptability, and availability over the counter. Well-defined clinical phenotypes of AD could optimally benefit from specific moisturizers. It is hoped that future studies may identify such differences by means of filaggrin mutation subtypes, confocal microscopic evaluation, pH, transepidermal water loss or presence of allergy specific IgE. Recommendations to improve the regular use of moisturizers among AD patients include measures that focus on treatment compliance, patient and caregiver education, appropriate treatment goals, avoidance of sensitizing agents, and collaboration with other relevant specialists | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Asia Pacific | |
| 650 | 4 | |a Classification | |
| 650 | 4 | |a Compliance | |
| 650 | 4 | |a Dermatitis, atopic | |
| 650 | 4 | |a Moisturizer | |
| 700 | 1 | |a Hebert, Adelaide Ann |e verfasserin |4 aut | |
| 700 | 1 | |a Dizon, Maria Victoria |e verfasserin |4 aut | |
| 700 | 1 | |a Van Bever, Hugo |e verfasserin |4 aut | |
| 700 | 1 | |a Tiongco-Recto, Marysia |e verfasserin |4 aut | |
| 700 | 1 | |a Kim, Kyu-Han |e verfasserin |4 aut | |
| 700 | 1 | |a Soebono, Hardyanto |e verfasserin |4 aut | |
| 700 | 1 | |a Munasir, Zakiudin |e verfasserin |4 aut | |
| 700 | 1 | |a Diana, Inne Arline |e verfasserin |4 aut | |
| 700 | 1 | |a Luk, David Chi Kang |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Asia Pacific allergy |d 2012 |g 6(2016), 2 vom: 01. Apr., Seite 120-8 |w (DE-627)NLM218656807 |x 2233-8276 |7 nnns |
| 773 | 1 | 8 | |g volume:6 |g year:2016 |g number:2 |g day:01 |g month:04 |g pages:120-8 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.5415/apallergy.2016.6.2.120 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 6 |j 2016 |e 2 |b 01 |c 04 |h 120-8 | ||